Oncology Venture, Innovation & Partnering Summit 2024 官方網站

連接投資者和商界領袖，加速腫瘤領域的創新

本次會議是一個有高級投資者、公司高管、企業家和商業領袖參加的特別活動。在輕鬆的人際交流環節中，您可以與未來的投資者和合作夥伴接觸。在行業主導的小組討論中，您將獲得關於癌症治療和診斷的資金籌集活動、目標和業務發展的戰略洞見。此外，在充滿活力的爐邊談話中，您還可以聽到腫瘤行業意見領袖的直率見解和商業建議，請您絕對不可錯過。

Cambridge Innovation Institute是組織涵蓋癌症治療藥物和診斷藥物開發各方面最尖端會議具有長達30年經驗的企劃組織，基於該傲人的實績，我們將舉辦一個專注於癌症領域業務發展的重要會議。本次會議將於2024年10月9日至10日在麻薩諸塞州劍橋市舉行。這是CII新設立的Cambridge VIP部門的一部分，該活動將吸引高級投資者、公司高管和腫瘤領域創新創業的領導者來此聚集。這次高水平的網絡交流活動由啟發性的行業主導型小組討論和爐邊談話組成，此外還提供了多個人際交流機會，讓創業者、投資者和潛在的企業收購者能夠建立有意義的人脈。參加本次會議，您將獲得關於業務合作、投資和公司戰略的寶貴戰略洞見、直率的展望和實用的商業建議。

會議特色：

獨家招待會和社交活動讓您可與投資者、首席執行官和製藥企業領袖互動。
透過小組討論從腫瘤學業務領導者那裡獲得可行的見解。
在輕鬆的氛圍中進行爐邊談話，您可以向腫瘤學高管學習並制定業務成功策略。
在主題限定的座談會上，與潛在的未來合作夥伴和投資者一起開創最及時話題的新天地。
參加我們的年度會議，加速癌症創新！

Cambridge VIP Attendee Demographics

2024年議程主題：

Future opportunities in oncology investments and strategies to de-risk
腫瘤學領域的未來投資和風險規避策略
Emerging oncology therapeutics and modalities: radiopharmaceuticals, antibody-drug conjugates, CAR T-cell therapy, etc.
抗癌新藥及方法：放射性藥物、抗體偶聯物、CAR-T細胞療法等
Policy implications affecting oncology investors and operators: Inflation Reduction Act, BIOSECURE Act, and an upcoming election
政策對癌症業界投資者和高管的影響：《通脹削減法案》（IRA）、《生物安全法案》和即將舉行的選舉
Cancer diagnostics, screening, and early detection
癌症診斷、篩查和早期發現

Where does Artificial Intelligence add value in oncology: from discovery to care delivery?
從發現到提供護理，人工智慧在腫瘤學領域的價值體現在哪裡？
Big pharma perspective on oncology venture, partnering, and M&A
大型製藥公司對腫瘤風險投資、合作夥伴關係和併購的看法
Is “precision medicine” working?
「精準醫療」有效嗎？
Innovation in oncology clinical trials
癌症臨床試驗的新突破
Improving oncology care delivery and health equity
改善癌症護理服務和健康公平
Ups and downs of immuno-oncology
免疫腫瘤學的興衰
How to deliver value-based care in oncology?
如何在腫瘤學領域提供基於價值的照護(value-based care)？

顧問委員會

Mara Aspinall

Partner, Illumina Ventures

Christiana Bardon, MD

Co-Managing Partner, MPM BioImpact

Andrea Bild, PhD

Program Manager, Advanced Research Projects Agency for Health (ARPA-H)

Derek DiRocco

Partner, RA Capital Management

Keith J. Figlioli

Managing Partner, LRVHealth

Ben Freeberg

Founder and Managing Partner, Oncology Ventures

Luba Greenwood

Managing Partner, Binney Street Capital, Dana-Farber Cancer Institute

Gregory Grunberg, MD

Head, Life Sciences (North America), Temasek

Sofia Guerra

Vice President, Bessemer Venture Partners

David Hirsch, MD, PhD

CEO, Alpha-9 Oncology

Karen Hong, PhD

Co-Founder and Co-Owner, Cold Spring Bio

Rachel Humphrey, MD

President and Founding CEO
Normunity

Roger Kitterman

Senior Vice President, Ventures and Business Development & Licensing and Managing Partner, Mass General Brigham Ventures

Selin Kurnaz, PhD

Co-Founder and CEO, Massive Bio

Manoja Lecamwasam, PhD

System Vice President, Intellectual Property and Life Sciences Innovation, CommonSpirit Health

Matt McAviney, MD

Partner, NEA

Marie-Claire Peakman, PhD

Partner, Pfizer Ventures; Executive Director, Worldwide Business Development, Pfizer

Chevon Rariy, MD

Chief Health Officer and Senior Vice President, Digital Health, Oncology Care Partners

Maya R. Said, ScD

Founder and CEO, Outcomes4Me

Ajit Singh, PhD

Partner, Artiman Ventures

Dave Stevenson

COO & Managing Director, Merck Global Health Innovation Fund

Shaquille Vayda

Principal, Lux Capital

Carrie Williams

Vice President and Partner, McKesson Ventures

Darshana Zaveri

Founder and Managing Partner, Catalyst Health Ventures

查看全部 »

Cambridge VIP Events Testimonials

“Always a highlight of my summer now is coming in for DHIS. I liked the sessions a lot and thought they were informative. I think you are hitting all the right topics, and I like that it is the right size crowd and venue. Nothing to change from my end.”

SVP Retail Health, CVS Health

“It was my first SCOPE Investor and Innovation Conference and it was such an eye-opening event to meet talents with very different background to discuss the achievement and future gaps in Clinical Research, Digital Health, Health Service Providers. The network opportunity is amazing!”

PhD, Managing Director, Boehringer Ingelheim Venture Fund

“A fantastic event in Minneapolis. The conversations surrounded the critical subjects in the medtech environment that are critical to the ongoing success of our industry. Great to see old friends and make new ones. If you did not have the chance to attend, check in for next year, great city, great people, and fantastic network.”

CEO, The Mullings Group

“Medtech MVP brings together thought leaders, top investors, and companies for a day and a half packed agenda on medtech and healthtech topics. Top great quality speakers provided valuable information that I can use in my day to day.”

Director, Managing Director, HSBC

“Incredibly informative presentations on responsible use of generative AI, women and families’ health and CVS’ healthcare ecosystem.”

Global Medical Affairs, Oncology Innovation in Care Lead, AstraZeneca

"DHIS West covered extremely timely and relevant topics, in an intimate collegial setting. It's a beautiful venue for networking as well, with lots of indoor and outdoor spaces to connect - rare in the winter! ”

Co-Founder & CEO, Cortica